Budapest, Hungary

Csaba Huszár

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sanofi. Active years: 2016.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Csaba Huszár

Introduction

Csaba Huszár is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of dronedarone, a medication used for treating heart conditions. With a total of 3 patents to his name, Huszár's work exemplifies innovation and dedication to improving healthcare.

Latest Patents

Huszár's latest patents include two novel processes for the preparation of dronedarone. The first patent describes a process for the preparation of dronedarone by oxidation of a hydroxyl group. This invention involves oxidizing a compound of a specific formula and isolating the resulting product, which can be converted into pharmaceutically acceptable salts. The second patent outlines a similar process, focusing on the oxidation of a sulphenyl group. This method also includes the isolation of the product and its potential conversion into a pharmaceutically acceptable salt.

Career Highlights

Csaba Huszár is currently employed at Sanofi, a global healthcare company. His work at Sanofi has allowed him to focus on innovative pharmaceutical processes that contribute to the development of effective treatments. His expertise in the field has positioned him as a valuable asset to the company and the industry.

Collaborations

Huszár has collaborated with several talented individuals, including Adrienn Hegedus and Zsolt Dombrády. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of innovative solutions in pharmaceutical research.

Conclusion

In summary, Csaba Huszár's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his commitment to advancing healthcare solutions. His work continues to impact the industry positively, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…